Amber Childers
Family Medicine · Due West, SCNPI 1285059303
Payments from drug & device makers
Across 377 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$688
- AbbVie$543
- AstraZeneca$493
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$466
- Lilly USA, LLC$379
- Takeda Pharmaceuticals U.S.A., Inc.$309
- plus $3K from 50 others
What the payments were for
- Food & beverage$5,885100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$5,885 in reported general payments places this provider in the 85th percentile of 2,153 family medicine providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 92 | $81,774 |
| OzempicSemaglutide | 67 | $74,172 |
| JardianceEmpagliflozin | 60 | $57,252 |
| RybelsusSemaglutide | 25 | $43,894 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 33 | $36,587 |
| LinzessLinaclotide | 27 | $25,013 |
| TrulicityDulaglutide | 19 | $24,859 |
| MounjaroTirzepatide | 23 | $24,165 |
| Repatha SureclickEvolocumab | 33 | $24,153 |
| XareltoRivaroxaban | 20 | $19,054 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 29 | $16,827 |
| TradjentaLinagliptin | 16 | $16,764 |
| FarxigaDapagliflozin Propanediol | 19 | $14,291 |
| Dexlansoprazole DrDexlansoprazole | 43 | $8,543 |
| Breo ElliptaFluticasone/Vilanterol | 13 | $7,387 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $688 | $118,06692 claims |
| PfizerEliquis | $226 | $81,77492 claims |
| Boehringer IngelheimJardiance, Tradjenta | $205 | $74,01676 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $379 | $49,02442 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $115 | $43,97546 claims |
| AbbVieLinzess | $543 | $25,01327 claims |
| Johnson & JohnsonXarelto | $37 | $19,05420 claims |
| AstraZenecaFarxiga | $493 | $14,29119 claims |
| Astellas Pharma US IncMyrbetriq | $90 | $4,76311 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Dexilant | $309 | $3,82611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,153 family medicine providers in South Carolina.
Other family medicine in Due West
- Cayce TangemanGoose Creek$8.4M
- Jeremy AckermannMoncks Corner$7.6M
- Kelly MoralesNorth Charleston$6.5M
- William ByarsGreer$4.8M
- James FranklinGreenville$3.5M
- Stephen GrubbLittle River$3.4M
- Jeffrey HarrisGreenville$3.4M
- Shannon ConradN Charleston$3.3M
- Tom ChristensenLittle River$3.1M
- Edward NewtonCharleston$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.